MarketCap
Facebook
X
Telegram
Interpace Biosciences ROCE Ratio | IDXG
Annual ROCE Ratio Interpace Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.26 | -365.72 | -7.12 | 6.23 | 14.94 | -96.75 | -39.1 | -18.39 | -18.99 | -43.74 | -61.01 | -12.89 | -11.36 | -2.4 | -6.99 | -9.93 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.26 | -365.72 | -40.93 |
Quarterly ROCE Ratio Interpace Biosciences
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -319.67 | -655.04 | -659.91 | -664.46 | -285.27 | -325.88 | -11.62 | -11.6 | -8.38 | -4.43 | -2.39 | -1.12 | 2.84 | 6.38 | 7.46 | 12.18 | 19.04 | 26.64 | 24.44 | 45.09 | 60.21 | 78.0 | 66.4 | 225.65 | 324.39 | 1712.95 | 1687.04 | 1680.5 | 1516.15 | 1388.05 | -20.35 | -27.36 | -28.97 | -15.5 | -6.78 | -106.12 | -124.85 | -150.55 | -158.93 | -190.43 | -126.5 | -132.64 | -98.79 | -109.73 | -81.85 | -47.85 | -15.98 | -21.43 | -12.74 | -3.13 | -1.72 | -3.51 | 1.18 | 2.91 | -3.07 | -2.78 | -2.58 | -3.89 | -3.37 | 0.29 | -1.59 | -2.06 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1712.95 | -664.46 | 71.5 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
DexCom
DXCM
|
21.72 | $ 79.92 | -1.42 % | $ 31.2 B |  USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 258.38 | -0.5 % | $ 28.7 B | USA |
 |
Castle Biosciences
CSTL
|
-8.4 | $ 34.41 | 0.07 % | $ 997 M | USA |
 |
IDEXX Laboratories
IDXX
|
61.76 | $ 696.77 | -1.4 % | $ 56 B | USA |
 |
Illumina
ILMN
|
29.64 | $ 214.84 | -2.69 % | $ 33.3 B | USA |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 3.05 | -3.48 % | $ 99 K | USA |
 |
Biodesix
BDSX
|
-39.8 | $ 10.04 | -2.95 % | $ 75.8 M | USA |
 |
BioNano Genomics
BNGO
|
-65.83 | $ 1.25 | 7.66 % | $ 6.81 M | USA |
 |
Bioventus
BVS
|
11.27 | $ 11.18 | 1.5 % | $ 745 M | USA |
 |
Fulgent Genetics
FLGT
|
-8.03 | $ 25.83 | -1.22 % | $ 795 M | USA |
 |
CareDx, Inc
CDNA
|
-9.52 | $ 80.78 | -4.31 % | $ 4.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Biomerica
BMRA
|
-202.28 | $ 1.48 | -4.52 % | $ 4.31 M | USA |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.39 | $ 204.62 | -1.43 % | $ 16 B |  Irlanda |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 0.29 | -9.5 % | $ 386 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
-9.56 | $ 13.19 | 6.46 % | $ 135 M |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
-36.38 | $ 2.37 | 15.05 % | $ 9.44 M |  Israel |
 |
Myriad Genetics
MYGN
|
-67.6 | $ 5.66 | -1.39 % | $ 524 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 4.78 | -1.24 % | $ 3.76 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | $ 50.52 | -0.07 % | $ 11 B |  Niderland |
 |
NeoGenomics
NEO
|
-9.11 | $ 16.97 | -3.58 % | $ 2.17 B | USA |
 |
OPKO Health
OPK
|
-6.58 | $ 1.71 | 0.58 % | $ 1.28 B | USA |
 |
Pacific Biosciences of California
PACB
|
-77.87 | $ 2.22 | -5.93 % | $ 666 M | USA |
 |
Neogen Corporation
NEOG
|
-1.03 | $ 11.67 | -3.44 % | $ 2.54 B | USA |
 |
Precipio
PRPO
|
-6.84 | $ 23.56 | 6.13 % | $ 37.8 M | USA |
 |
Personalis
PSNL
|
-29.9 | $ 15.9 | -0.31 % | $ 1.42 B | USA |
 |
Sotera Health Company
SHC
|
10.33 | $ 16.25 | -1.16 % | $ 4.61 B | USA |
 |
Quidel Corporation
QDEL
|
69.35 | $ 11.56 | -4.43 % | $ 487 M | USA |
|
Centogene N.V.
CNTG
|
-87.78 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 5.88 | 10.08 % | $ 2.11 B | Irlanda |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-119.91 | - | 0.12 % | $ 80.1 M | China |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
22.99 | $ 26.91 | 0.9 % | $ 602 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 132.17 | -2.35 % | $ 7.9 B | USA |
 |
Organovo Holdings
ONVO
|
1045.22 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
75.43 | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
3.29 | - | -0.91 % | $ 14.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
1.87 | - | - | $ 2.69 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 476.29 | -0.09 % | $ 28.4 B | USA |
 |
Exagen
XGN
|
-32.08 | $ 5.26 | -25.92 % | $ 113 M | USA |
 |
Celcuity
CELC
|
-40.76 | $ 67.13 | -4.11 % | $ 3.14 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.9 | $ 370.89 | -0.25 % | $ 30.9 B | USA |